Featured Research

from universities, journals, and other organizations

Rate of childhood peanut allergies more than tripled from 1997 to 2008

Date:
May 13, 2010
Source:
The Mount Sinai Hospital / Mount Sinai School of Medicine
Summary:
Results of a nationwide telephone survey have shown that the rate of peanut allergies in children more than tripled from 1997 to 2008.

Results of a nationwide telephone survey have shown that the rate of peanut allergies in children more than tripled from 1997 to 2008. The data are reported in the May 12 issue of the Journal of Allergy and Clinical Immunology.

Led by Scott H. Sicherer, MD, Professor of Pediatrics, Jaffe Food Allergy Institute at Mount Sinai School of Medicine, researchers surveyed a total of 5,300 households, representing 13,534 individuals in 2008, a response rate of 42 percent. The survey was previously conducted in 1997 and 2002, with a 52 percent and 67 percent response rate, respectively. In 2008, 1.4 percent of children in the survey were reported to have peanut allergies, as opposed to just 0.4 percent in 1997. The prevalence of combined peanut or tree nut allergies in children was 2.1 percent in 2008, compared to 0.6 percent in 1997.

"These results show that there is an alarming increase in peanut allergies, consistent with a general, although less dramatic, rise in food allergies among children in studies reported by the CDC," said Dr. Sicherer. "The data underscore the need for more study of these dangerous allergies."

The study is the first of its kind to incorporate all age groups within a national sample, and to use the same study methods over such an extended period of time. The study is also the first U.S. study to evaluate allergies to sesame seeds. Peanut and/or tree nut allergies remained steady among adults, with a rate of 1.3 percent. Tree nut allergies alone in children also increased from 0.2 percent in 1997 to 1.1 percent in 2008. Sesame allergy was reported in 0.1 percent of children and adults.

"Our research shows that more than three million Americans report peanut and/or tree nut allergies, representing a significant health burden," said Dr. Sicherer. "The data also emphasize the importance of developing better prevention and treatment strategies."

Several theories exist as to why there could be a spike in food allergies. The main theory to explain a rise in allergic disease, including food allergy, is the "hygiene hypothesis" that generally suggests that "clean living" with less farm living and the use of medications to prevent and quickly treat infections leaves our immune system in a state that is more prone to attack harmless proteins like those in foods, pollens, and animal dander. Other theories include the timing of introduction of the food and how the food is prepared.

The authors caution that the study has limitations inherent to telephone surveys, which may over-represent households of high socioeconomic status because homes without telephones are excluded. There are also limitations in the self-reported nature of the survey, and identifying "true" allergy. However, the rate of childhood peanut allergy estimated in the current study is similar to results from studies using different methods in Canada, Australia and the UK.


Story Source:

The above story is based on materials provided by The Mount Sinai Hospital / Mount Sinai School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Scott H. Sicherer, Anne Muñoz-Furlong, James H. Godbold, Hugh A. Sampson. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. The Journal of Allergy and Clinical Immunology, May 12, 2010 DOI: 10.1016/j.jaci.2010.03.029

Cite This Page:

The Mount Sinai Hospital / Mount Sinai School of Medicine. "Rate of childhood peanut allergies more than tripled from 1997 to 2008." ScienceDaily. ScienceDaily, 13 May 2010. <www.sciencedaily.com/releases/2010/05/100512112320.htm>.
The Mount Sinai Hospital / Mount Sinai School of Medicine. (2010, May 13). Rate of childhood peanut allergies more than tripled from 1997 to 2008. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/05/100512112320.htm
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Rate of childhood peanut allergies more than tripled from 1997 to 2008." ScienceDaily. www.sciencedaily.com/releases/2010/05/100512112320.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins